Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioLife Solutions Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
BLFS
Nasdaq
3841
https://www.biolifesolutions.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioLife Solutions Inc
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2022 Earnings Call Transcript
- Mar 21st, 2023 2:46 am
Q4 2022 BioLife Solutions Inc Earnings Call
- Mar 17th, 2023 12:39 pm
BioLife Solutions Reports Preliminary and Unaudited 2022 Fourth Quarter and Full Year Financial Results
- Mar 16th, 2023 8:03 pm
Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year?
- Mar 13th, 2023 1:40 pm
BioLife Solutions Reports Immaterial Financial Exposure to Silicon Valley Bank
- Mar 10th, 2023 8:38 pm
BioLife Solutions to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 16, 2023
- Mar 9th, 2023 9:03 pm
BioLife Solutions Launches Ultraguard™ -70°C Phase Change Material (PCM) Accessory to Provide Backup Cooling in ULT Freezers and Dry Ice Alternative for Benchtop Biologic Material Storage
- Mar 1st, 2023 1:03 pm
Is Annovis Bio (ANVS) Stock Outpacing Its Medical Peers This Year?
- Feb 17th, 2023 2:40 pm
iVexSol® Closes $23.8M Series A-3 Financing; Funds to Revolutionize the Production of Lentiviral Vectors
- Jan 26th, 2023 1:00 pm
BioLife Solutions Announces 2023 Analyst Day & Participation in Upcoming Investor Conferences
- Jan 17th, 2023 1:04 pm
BioLife Solutions Named One of Seattle Business Magazine's Washington's Best Companies to Work For
- Jan 10th, 2023 1:05 pm
BioLife Solutions Announces 2022 Fourth Quarter and Full Year Preliminary Unaudited Revenue and Introduces 2023 Revenue Guidance
- Jan 9th, 2023 1:05 pm
Is BioLife Solutions, Inc. (NASDAQ:BLFS) Potentially Undervalued?
- Jan 6th, 2023 12:31 pm
BioLife Solutions to Announce Preliminary 2022 Revenue and Introduce 2023 Revenue Guidance on January 9, 2023
- Dec 19th, 2022 1:03 pm
Should You Invest in BioLife Solutions (BLFS)?
- Dec 18th, 2022 9:43 pm
Investors push BioLife Solutions (NASDAQ:BLFS) 11% lower this week, company's increasing losses might be to blame
- Dec 10th, 2022 12:12 pm
BioLife Solutions Expands Intellectual Property Estate
- Nov 21st, 2022 1:05 pm
BioLife Solutions Named in BioSpace Best Places to Work in Biopharma 2023 Report
- Nov 17th, 2022 1:05 pm
BioLife Solutions Third Quarter 2022 Earnings: Misses Expectations
- Nov 11th, 2022 10:27 am
BioLife Solutions, Inc. (BLFS) Reports Q3 Loss, Lags Revenue Estimates
- Nov 9th, 2022 11:05 pm
Scroll